These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2641563)

  • 1. Use of imipramine in children with intractable asthma and psychiatric disorders: a warning.
    Kanner AM; Klein RG; Rubinstein B; Mascia A
    Psychother Psychosom; 1989; 51(4):203-9. PubMed ID: 2641563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine treatment of children with separation anxiety disorder.
    Klein RG; Koplewicz HS; Kanner A
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):21-8. PubMed ID: 1347039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of tricyclic antidepressants in childhood asthma: a case series and review.
    Wamboldt MZ; Yancey AG; Roesler TA
    J Child Adolesc Psychopharmacol; 1997; 7(1):45-64. PubMed ID: 9192541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. School phobia: diagnostic considerations in the light of imipramine effects.
    Gittelman-Klein R; Klein DF
    J Nerv Ment Dis; 1973 Mar; 156(3):199-215. PubMed ID: 4698665
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric cardiovascular effects of imipramine and desipramine.
    Bartels MG; Varley CK; Mitchell J; Stamm SJ
    J Am Acad Child Adolesc Psychiatry; 1991 Jan; 30(1):100-3. PubMed ID: 2005043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine.
    Strober M; Freeman R; Rigali J; Schmidt S; Diamond R
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):16-20. PubMed ID: 1537769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic drug therapy in children and adolescents.
    Wiener JM
    Psychosomatics; 1982 May; 23(5):488-91, 494-5. PubMed ID: 6125987
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical indicators related to "shock" doses of imipramine in endogenous depressive syndromes].
    Strzyzewski W; Rajewski A; Rozek B; Szajnerman Z; Rajewska J; Rybakowski J
    Psychiatr Pol; 1982; 16(3):121-7. PubMed ID: 6757996
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine in adolescent major depression: plasma level and clinical response.
    Ryan ND; Puig-Antich J; Cooper T; Rabinovich H; Ambrosini P; Davies M; King J; Torres D; Fried J
    Acta Psychiatr Scand; 1986 Mar; 73(3):275-88. PubMed ID: 3716845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA; Baldwin DS; Priest RG; Steinert J; Patel A; Herrington RN; Livingston HM
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine.
    Wells BG; Evans RL; Ereshefsky L; Antal EJ; Lobeck F; Rawls WN; Hamann G; Grimmig J; Smith RB
    J Clin Psychiatry; 1988 Oct; 49(10):394-9. PubMed ID: 3049560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative safety of single versus divided dose imipramine in adolescent major depression.
    Ryan ND; Puig-Antich J; Cooper TB; Rabinovich H; Ambrosini P; Fried J; Davies M; Torres D; Suckow RF
    J Am Acad Child Adolesc Psychiatry; 1987 May; 26(3):400-6. PubMed ID: 3597296
    [No Abstract]   [Full Text] [Related]  

  • 14. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP; Galinowski A; Lehert P; Lemonnier F; Lôo H
    Encephale; 1993; 19(4):333-40. PubMed ID: 8275921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine and weight gain during the treatment of recurrent depression.
    Frank E; Kupfer DJ; Bulik CM; Levenson JA
    J Affect Disord; 1990 Nov; 20(3):165-72. PubMed ID: 2148336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Imipramine and neuro-psychiatry. Retrospective study of 557 out-patients treated in a neuro-psychiatric unit (author's transl)].
    Brion S; Boulenger JP
    Encephale; 1982; 8(1):49-63. PubMed ID: 7094871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
    Campbell M; Cueva JE
    J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1262-72. PubMed ID: 7592263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders.
    Salzmann E; Robin JL
    Neuropsychobiology; 1995; 31(2):68-75. PubMed ID: 7760988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression, anxiety and suicidal behaviour in children and adolescents with Haemophilia.
    Ghanizadeh A; Baligh-Jahromi P
    Haemophilia; 2009 Mar; 15(2):528-32. PubMed ID: 19187190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.